Riskpilot← Back to searchSign inGet full accessNYDALEN TANNLEGESENTER AS
ASActiveOrg 816796962Sandakerveien 114B, 0484 OsloDental practice care activities · NACE 8623Est. 201611 employees
Revenue 2025
NOK 26,8M
+5% vs 2024
EBITDA margin
5.2%
-55% vs 2024
Equity ratio
44.7%
Financial strength
Net profit 2025
NOK 683K
-68% vs 2024
| Revenue | NOK 26,8M | +5% |
| EBITDA | NOK 1,4M | -55% |
| Net profit | NOK 683K | -68% |
| Total assets | NOK 6,2M | -21% |
| Equity | NOK 2,8M | +7% |
| Employees | 11 | — |
Legal name
NYDALEN TANNLEGESENTER AS
Org number
816796962
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
24. februar 2016
Share capital
NOK 48 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Tannlegevirksomhet og det som dertil hører til, herunder også deltagelse i andre selskap med lignende formål.
Address
Sandakerveien 114B, 0484 Oslo
Phone
+4722230303
Email
info@nydalentannlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 19 973 | 16 036 | 17 446 | 25 430 | 26 764 |
| Staff expenses | −2 941 | −2 099 | −2 690 | −4 098 | −4 499 |
| EBITDA | 223 | 120 | −4 | 3 111 | 1 386 |
| Depreciation & amort. | −298 | −297 | −343 | −395 | −522 |
| EBIT | −75 | −176 | −346 | 2 716 | 864 |
| Net financials | −16 | −152 | 18 | 33 | 16 |
| Profit before tax | −91 | −329 | −328 | 2 749 | 880 |
| Tax | −20 | −72 | −23 | 614 | 197 |
| Net profit | −71 | −256 | −305 | 2 135 | 683 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 992 | 4 950 | 5 536 | 7 761 | 6 170 |
| Equity | 2 800 | 3 444 | 3 139 | 2 573 | 2 756 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 192 | 1 506 | 2 398 | 5 188 | 3 413 |
| Total debt | 2 192 | 1 506 | 2 398 | 5 188 | 3 413 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20212025
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20212025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20212025
Asset turnover
4.34×
This company
1.12×
Market median
+287% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
BN Chief Executive Officer | Chief Executive Officer | 2016 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Inovia Invest As
NYDALEN TANNLEGESENTER AS Board members of NYDALEN TANNLEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Burim Nurkasa | Chief Executive Officer | 0 companies |
| Mohamed Mehdi Omrani | Chief Executive Officer | 0 companies |
| Amjad Hosseini | Chairman | 0 companies |